Letters in Drug Design & Discovery
Title:Meet the Editorial Board
Volume: 12 Issue: 3
Author(s): James David Adams
Affiliation:
Export Options
About this article
Cite this article as:
Adams David James , Meet the Editorial Board, Letters in Drug Design & Discovery 2015; 12 (3) . https://dx.doi.org/10.2174/157018081203141202095204
DOI https://dx.doi.org/10.2174/157018081203141202095204 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
29
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot Topic: Protease Inhibitors in Drug Discovery (Guest Editor: Francis X. Tavares)]
Current Topics in Medicinal Chemistry Nucleotide-Derived Thrombin Inhibitors: A New Tool for an Old Issue
Cardiovascular & Hematological Agents in Medicinal Chemistry An Overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases
Mini-Reviews in Medicinal Chemistry Targeting of Antioxidant and Anti-Thrombotic Drugs to Endothelial Cell Adhesion Molecules
Current Pharmaceutical Design Current Genomics in Cardiovascular Medicine
Current Genomics Applications of FDG-PET/CT in Assessment of Vascular Infection and Inflammation
Current Molecular Imaging (Discontinued) COX-2 Inhibitors Celecoxib and Parecoxib: Valuable Options for Postoperative Pain Management
Current Topics in Medicinal Chemistry Clinical Value of Prostacyclin and its Analogs in the Management of Pulmonary Arterial Hypertension
Current Vascular Pharmacology Targeting Angiogenesis in Ovarian Carcinoma
Current Cancer Therapy Reviews Postmenopausal Hormone Therapy
Current Women`s Health Reviews Acute Phase Treatment of Pulmonary Embolism
Current Vascular Pharmacology Role of Thrombin Activatable Fibrinolysis Inhibitor in Endocrine and Cardiovascular Disorders: An Update
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Carbohydrates in Therapeutics
Cardiovascular & Hematological Agents in Medicinal Chemistry Von Willebrand Factor and Cardiovascular Disease: From a Biochemical Marker to an Attractive Therapeutic Target
Current Vascular Pharmacology Direct Thrombin Inhibitors for Treatment of Heparin Induced Thrombocytopenia, Deep Vein Thrombosis and Atrial Fibrillation
Current Pharmaceutical Design Prostacyclin Analogues: Prevention of Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Heterogeneity of Synthetic Factor Xa Inhibitors
Current Pharmaceutical Design Fenofibrate, Homocysteine and Renal Function
Current Vascular Pharmacology Twin-to-Twin Transfusion Syndrome: From Placental Anastomoses to Long-Term Neurodevelopmental Outcome
Current Pediatric Reviews Coronary Magnetic Resonance Imaging
Current Pharmaceutical Design